Skip to content

CTI BIOPHARMA CORP: filings

Every CTI BIOPHARMA CORP annual and quarterly report in the SEC record with the published financial measures it tagged, 50 filings, each linked to its SEC index.

Filing record ends 2023-05-15

The latest filing in this captured record is a 10-Q filed 2023-05-15. No later filing is in the SEC companyfacts record captured on 2026-09-22. CTI BIOPHARMA CORP may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2023-05-15fiscal Q1 202340840000891293-23-000015
10-K2023-03-06fiscal FY 202249970000891293-23-000011
10-Q2022-11-07fiscal Q3 2022421240000891293-22-000054
10-Q2022-08-08fiscal Q2 2022411160000891293-22-000043
10-Q2022-05-12fiscal Q1 202240840000891293-22-000026
10-K2022-03-31fiscal FY 202140790000891293-22-000010
10-Q2021-11-12fiscal Q3 2021351060000891293-21-000044
10-Q2021-08-05fiscal Q2 202134980000891293-21-000041
10-Q2021-05-06fiscal Q1 202129620000891293-21-000025
10-K2021-03-17fiscal FY 202040790000891293-21-000008
10-Q2020-11-10fiscal Q3 202033980000891293-20-000058
10-Q2020-08-07fiscal Q2 202032920000891293-20-000051
10-Q2020-05-15fiscal Q1 202034720000891293-20-000041
10-K2020-03-13fiscal FY 201942840000891293-20-000012
10-Q2019-11-04fiscal Q3 2019391110000891293-19-000065
10-Q2019-08-01fiscal Q2 2019391060000891293-19-000058
10-Q2019-05-02fiscal Q1 201937760000891293-19-000039
10-K2019-03-13fiscal FY 201842850000891293-19-000021
10-Q2018-11-01fiscal Q3 2018381010000891293-18-000095
10-Q2018-08-03fiscal Q2 2018431190000891293-18-000078
10-Q2018-05-03fiscal Q1 201838790000891293-18-000055
10-K2018-03-07fiscal FY 2017441540000891293-18-000043
10-Q2017-11-07fiscal Q3 201736960000891293-17-000114
10-Q2017-08-04fiscal Q2 2017401120000891293-17-000089
10-Q2017-05-03fiscal Q1 201736740000891293-17-000054
10-K2017-03-02fiscal FY 2016401340000891293-17-000030
10-Q2016-11-08fiscal Q3 201633880000891293-16-000197
10-Q2016-08-04fiscal Q2 201632860000891293-16-000178
10-Q2016-05-10fiscal Q1 201636740000891293-16-000162
10-K2016-02-17fiscal FY 2015401420000891293-16-000105
10-Q2015-11-05fiscal Q3 2015371020001564590-15-009731
10-Q2015-08-06fiscal Q2 201532860001564590-15-006497
10-Q2015-05-06fiscal Q1 201532650001564590-15-003443
10-K2015-03-12fiscal FY 2014391380001564590-15-001582
10-Q2014-10-31fiscal Q3 2014371050001564590-14-004755
10-Q2014-08-04fiscal Q2 201432860001564590-14-003099
10-Q2014-04-29fiscal Q1 201431640001193125-14-167552
10-K2014-03-04fiscal FY 2013421330001193125-14-082598
10-Q2013-10-30fiscal Q3 201335880001193125-13-418841
10-Q2013-07-31fiscal Q2 201335870001193125-13-312843
10-Q2013-05-02fiscal Q1 201335670001193125-13-196421
10-K2013-02-28fiscal FY 2012341180001193125-13-084836
10-Q2012-11-01fiscal Q3 201230780001193125-12-446683
10-Q2012-08-02fiscal Q2 201230780001193125-12-332253
10-Q2012-04-20fiscal Q1 201231640001193125-12-173261
10-K2012-03-08fiscal FY 201134850001193125-12-103788
10-Q2011-10-25fiscal Q3 201132780001193125-11-279957
10-Q2011-07-28fiscal Q2 201132790001193125-11-200398
10-Q2010-10-28fiscal Q3 201032800001193125-10-239363
10-Q2010-08-06fiscal Q2 201032800001193125-10-180853

Inspect the source

Entity
CTI BIOPHARMA CORP / CIK 0000891293
Captured
SEC response SHA-256
4ee4ccdafdc702cf7640160462fbdf4d50f1957e4319a255a21075530c4cb447

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000891293.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))